Board

Dr. Gerhard Heßler (Chair), Sanofi-Aventis Deutschland, Frankfurt a.M.
Dr. Tatjana Ross (Deputy Chair), Merck KGaA, Darmstadt
Prof. Dr. Christian Ducho, Saarland University, Saarbrücken
Prof. Dr. Anna Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken
Dr. Christian Kuttruff, Boehringer Ingelheim International GmbH, Biberach
Prof. Dr. Holger Stark, Heinrich Heine University Düsseldorf
Permanent guest of the Executive Board
Dr. Philipp Barbie, Bayer AG, Berlin (NextGenMedChem representative)

Dr. Franz von Nussbaum (Chair), Nuvisan ICB GmbH, Berlin
Prof. Dr. Anna Hirsch (Deputy Chair), Helmholtz Institute for Pharmaceutical Research (HIPS), Saarbrücken
Dr. Horst Dollinger, Schemmerhofen
Prof. Dr. Christian Ducho, Saarland University, Saarbrücken
Dr. Gerhard Heßler, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main
Prof. Dr. Stefan Laufer, University of Tübingen